Table 3.
Total Cohort (n=29) | −CAD (n=21) | +CAD (n=8) | P-value* | |
---|---|---|---|---|
LVIDd (cm) | 4.7±0.6 | 4.7±0.6 | 4.6±0.6 | ns |
LVIDs (cm) | 3.2±0.8 | 3.3±0.8 | 3.0±0.7 | ns |
IVSd (cm) | 0.9±0.3 | 0.9±0.3 | 1.0±0.2 | ns |
PWd (cm) | 0.9±0.2 | 0.8±0.1 | 1.0±0.2 | ns |
LVEDV (mL) | 100±22 | 100±24 | 99±20 | ns |
LVESV (mL) | 38±12 | 39±11 | 38±14 | ns |
LVEF (%) | 63±7 | 63±6 | 63±9 | ns |
LV mass index (g/m2) | 77±25 | 74±24 | 85±28 | ns |
Stroke volume (mL) | 72±19 | 73±22 | 72±12 | ns |
Cardiac output (L/min) | 5.1±1.5 | 5.1±1.7 | 5.0±1.1 | ns |
Stroke work (mL×mm Hg) | 8729±1906 | 8581±2001 | 9101±1717 | ns |
Myocardial work (×1000 mL×mm Hg/min) | 1032±328 | 978±333 | 1170±294 | ns |
IVSd, diastolic interventricular septum thickness; LVEDD, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic volume; LVIDd, diastolic left ventricular diameter, LVIDs, systolic left ventricular diameter; PWd, diastolic posterior wall thickness.
p-value for comparison of −CAD and +CAD cohorts.